Cadila’s Commitment Stories, August 2020

The month of August, for us, was a bag of varied initiatives. We celebrated innovations and initiatives that will impact the health of millions of lives, in one way or the other. When the world is fighting the crisis, the team at Cadila Pharmaceuticals, one of the top pharma companies in India, is working hard to impact the lives of our consumers and our society.

Our drug, Sepsivac, received the Pharma Excellence Award for being one of the most promising drugs in the fight against COVID-19. Psoriasis is a common skin disorder that affects many people. We celebrated Psoriasis Awareness month to raise awareness about the issue and break the stigma around it. Cadila Pharma also launched a new biosimilar – NuPTH for the treatment of Osteoporosis and distributed 3000 essential kits to govt. school students who were missing out on nutritious mid-day meals due to the lockdown.

We sincerely believe in the ethos of care and everyday strive to bring an element of care in the lives of people around us. Read more of our care stories for the month of August-

Sepsivac® receives COVID-19 Pharma Excellence Award
Sepsivac®, the latest innovation by Cadila Pharmaceutical recently received the prestigious Pharma Excellence Award at the Emerging Dimensions in Pharma Excellence e-Summit organised by Express Pharma and HEAL Health Connect Solutions. This honour was awarded to Sepsivac® for being one of the most promising drugs in the fight against COVID-19.

Read the complete story here.

Cadila Pharma and Akshaya Patra help 3000 students
Cadila Pharma, one of the top pharma companies in India, in association with Akshaya Patra foundation distributed kits with essential food items to the families of 3000 students in the month of July and August to continue providing healthy meals to these students.

Read the complete story here.

Cadila Pharmaceuticals launches NuPTH for Osteoporosis
Ahmedabad-based Cadila Pharmaceuticals Limited has announced the launch of NuPTH an Osteoporosis biosimilar of Forteo in India. The biosimilar is used for treatment of osteoporosis and in patients with increased risk of fracture.

Read the complete story here.

Make In India – A huge opportunity for the Pharmaceutical Industry
In the July edition of Pharma Bio World, Dr Manjul Joshipura, Senior Vice President, Innovations and New Product Development, Cadila Pharmaceuticals talks about how India has made a lot of progress in the formulations industry and yet we still have a long way to go when it comes to the API industry. However, with Make in India initiative, it is a significant opportunity for the pharma industry to make a mark in the pharmaceutical world.

Read the complete story here.

Future leaders in pharmaceutical industry need to challenge the status quo and keep learning
Being a future leader in today’s pharmaceuticals industry, you need to not only remain sharp but also be willing to take up new challenges. This is vital when you are responsible for 400 employees. “Every day is a brand new day, especially in the new normal,” points out Vibhasha Kumari as she shares her story and the experiences she gathered in the past 2 years.

Read the complete story here.

What is Psoriasis? What causes Psoriasis? – Two important questions answered
According to the International Federation of Psoriasis Associations (IFPA), Psoriasis affects nearly 3% of the world population. Most often mistaken as a skin condition, it is an immune condition that can have a physical and psychological impact. People affected with psoriasis often face discrimination and embarrassment in public places simply because others fear that it is contagious, when in fact, it is not.

August is celebrated as Psoriasis Awareness Month, to educate the public and dispel myths associated with the disease. We asked Dr Pratik Patel to educate us about psoriasis and what all one needs to know about this disease.

Read the complete story here.